Flowable Hemostats Market – By Material (Bovine, Porcine), Application (General Surgery, Cardiovascular, Orthopedic, Gynecological, Neurosurgery, Reconstructive Surgery), End-use (Hospitals & Clinics, ASC’s), Global Forecast (2024 – 2032)

Flowable Hemostats Market Size

Flowable Hemostats Market size was valued at USD 723.8 million in 2023 and is anticipated to grow at a CAGR of 5.7% between 2024 and 2032. One of the primary drivers is the increasing number of surgeries and trauma cases, which has led to a higher demand for effective hemostatic agents to control bleeding.

To get key market trends

  Download Free Sample

Additionally, the rising prevalence of chronic diseases and the subsequent increase in surgical interventions have fueled the market growth. Further, the advancements in surgical techniques and the growing adoption of minimally invasive procedures have also contributed to the demand for flowable hemostats, as these products are often used to achieve hemostasis in such procedures. Furthermore, the development of innovative flowable hemostats with improved efficacy and safety profiles is also a significant factor contributing to market expansion.
 

What are the growth opportunities in this market?

 Download Free Sample

Flowable hemostats are used to control bleeding during surgical procedures. They are typically delivered in a liquid or gel form and can be applied directly to the bleeding site. These hemostats work by promoting clot formation, which helps to seal off blood vessels and stop bleeding. Flowable hemostats are particularly useful in procedures where traditional methods such as sutures or pressure are not effective or feasible, such as in minimally invasive surgeries or surgeries involving delicate tissues.

Flowable Hemostats Market Trends

• Increasing incidence of accidents and trauma cases is a significant driver of the market. For instance, as per the American Association for the Surgery of Trauma, in the U.S., injury accounts for over 150,000 deaths and over 3 million non-fatal injuries per year. Around the world, injury is responsible for more than 5 million deaths per year.
• Accidents, including those from vehicular crashes, industrial mishaps, and sports injuries, often result in severe bleeding that requires immediate and effective hemostatic treatment to control.
• Flowable hemostats, with their ability to stop bleeding quickly and efficiently, play a crucial role in managing these cases.
• Thus, as the number of accidents and trauma cases continues to rise globally, especially in developing regions with expanding industrial and transportation sectors, the demand for novel surgical hemostats is expected to increase significantly, thereby driving the growth of market.

Flowable Hemostats Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

Based on origin, the market is segmented into bovine and porcine. The bovine segment dominated the market is 2023 and accounted for USD 419.2 million.

• Bovine origin products have been widely used in surgical procedures due to their effectiveness in promoting hemostasis. These products are known for their rapid action and ability to control bleeding in various surgical settings, including cardiovascular, orthopedic, and general surgeries.
• Additionally, these products are often preferred for their biocompatibility and safety profile, making them suitable for use in a wide range of patients.
• Thus, the established efficacy and safety of bovine origin products, along with their availability and cost-effectiveness, contribute to their dominant position in the market.

Learn more about the key segments shaping this market

 Download Free Sample

Based on application, the flowable hemostats market is segmented into general surgery, cardiovascular surgery, orthopedic surgery, gynecological surgery, neurosurgery, reconstructive surgery, and other applications. The orthopedic surgery segment dominated the market with 18.6% of market share in 2023

• The increasing number of orthopedic surgeries, fueled by factors such as the rising prevalence of orthopedic disorders, sports injuries, and the aging population, is driving the demand for flowable hemostats.
• For instance, statistics show that in 2022, around 18,577,953 orthopedic procedures were performed in the U.S.
• Additionally, advancements in hemostatic agents, such as improved efficacy and reduced risk of adverse effects, are further contributing to their growing adoption in orthopedic surgeries, solidifying their prominent market position.

Based on end-use, the flowable hemostats market is categorized into hospitals & clinics, Ambulatory Surgical Centers (ASC’s), and other end-users. The hospitals & clinics segment dominated the market in 2023 and is predicted to grow at CAGR of 5.8% over the forecast period.

• Hospitals & clinics serve as the primary settings for surgical procedures, where hemostats are commonly used to control bleeding. The high volume of surgical procedures performed in hospitals and clinics, ranging from routine surgeries to complex interventions, contributes to the substantial demand for flowable hemostats.
• Additionally, the increasing prevalence of chronic diseases and the rising number of surgical interventions globally are driving the adoption of these hemostats in hospitals and clinics, thereby contributing the segment growth.

Looking for region specific data?

 Download Free Sample

North America flowable hemostats market is anticipated to grow at a CAGR of 5.4% over the forecast years to reach USD 404.8 million by 2032.

• The region boasts a well-established healthcare infrastructure and a high adoption rate of advanced medical technologies, contributing to the increased use of flowable hemostats in various medical procedures.
• Additionally, the presence of leading market players and their focus on research and development activities for innovative product launches further propels market growth in North America.
• Moreover, favorable reimbursement policies and a growing number of surgical procedures in the region also contribute to the high market share of North America in the market.

U.S. flowable hemostats market was valued at USD 232.7 million in 2023.

• The U.S. holds a significant market share in the market, largely due to its advanced healthcare infrastructure, high adoption rates of advanced medical technologies, and robust research and development activities in the medical field.
• Further, the country's large population, coupled with a high prevalence of chronic diseases and a growing number of surgical procedures, drives the demand for flowable hemostat.

Germany has emerged as a key player in the global market for flowable hemostats, showcasing high growth potential.

• Factors such as the rising prevalence of chronic diseases, increasing number of surgeries, and advancements in healthcare infrastructure are driving the demand for flowable hemostats in the country.
• Additionally, Germany's strong healthcare system, with a focus on quality care and technological innovation, is further propelling market growth.
• Moreover, the growing adoption of minimally invasive surgical procedures, which often require flowable hemostats for effective hemostasis, is contributing to the expanding market size.

India flowable hemostats market is anticipated to witness lucrative growth between 2024 – 2032.

• India has emerged as a promising market for flowable hemostats, showing significant growth potential. Several factors contribute to this trend, including the increasing prevalence of chronic diseases which often require surgical interventions.
• Moreover, the rising geriatric population in India is driving the demand for surgical procedures, further fueling the need for flowable hemostats.
• Furthermore, the rise in disposable incomes and the expanding middle class are expected to boost the demand for quality healthcare services, including surgical interventions, thereby creating a conducive environment for the growth of the market in India.

Flowable Hemostats Market Share

The market is characterized by intense competition among key players striving to meet the growing demand for hemostatic agents. The competitive landscape is shaped by factors such as technological innovation, regulatory compliance, market penetration strategies, and customer preferences, driving companies to continuously adapt and innovate to maintain their market shares.

Flowable Hemostats Market Companies

Prominent players operating in the flowable hemostats industry include

• 3D Matrix Medical Technology
• Aegis Lifesciences Private Limited
• Baxter International Inc.
• CR Bard Inc. (Becton, Dickinson, and Company)
• Ethicon, Inc. (Johnson & Johnson)
• Ferrosan Medical Devices A/S
• Integra LifeSciences Corporation
• Medcura Inc.
• Pfizer, Inc.
• Teleflex Incorporated

Flowable Hemostats Industry News

• In April 2023, Baxter International Inc. unveiled multiple new additions to its surgical portfolios at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo 2023, including the launch of Floseal + Recothrom flowable hemostat. This helped the company to expand its product offerings and increase the reach of its product.
• In December 2022, Medcura Inc. received FDA breakthrough device designation for its LifeGel flowable technology that controls bleeding during surgery, for procedures where swelling cannot be tolerated. This helped the company expand its sales in the U.S.
• In December 2018, Baxter International Inc. introduced the disposable curved applicator, which enhances the delivery experience of its floseal hemostatic matrix product line for procedures in the otolaryngology, and head and neck surgical specialty. This helped the company widen the application of its product.

The flowable hemostats market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments

Click here to Buy Section of this Report

Market, By Origin

• Bovine
• Porcine

Market, By Application

• General surgery
• Cardiovascular surgery
• Orthopedic surgery
• Gynecological surgery
• Neurosurgery
• Reconstructive surgery
• Other applications

Market, By End-use

• Hospitals & clinics
• Ambulatory surgical centers (ASCs)
• Other end-users

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa